Skip to main content

Actemium (Promatic w)

Actemium Belgium has developed an established reputation in advice, study, realization and support for industrial processes in electricity, instrumentation, automation and assembly, including the offer of a whole range of service possibilities and complete training programmes. Website
Read More

ATB Therapeutics

ATB Therapeutics has engineered a proprietary technology to manufacture a unique kind of immunotherapeutic designed to combine very high efficacy with unprecedent safety profile. ATB Therapeutics was funded in 2017 and aims to generate a pipeline of assets for hard-to-treat hematological and solid cancers. The company is now entering preclinical stage. Website
Read More

Targetum

Chitosan-based Targeting Drug Delivery Systems (Cs-tDDS) and their Proof of Concept Today, the most efficient therapeutic approaches in cancer rely on targeting the tumoral cells in order to enhance the therapeutic effect of the drug, to decrease its dosage and to limit its side effects. The TARGETUM Project aims at...
Read More

Valostem

Development of new cell-based in vitro models for ADME/Toxicity screening, based on human adult progenitor/stem cells Characterization of a new drug candidate during preclinical evaluation includes, in addition to potency and safety an assessment of drug metabolism and pharmacokinetics. Drug metabolism studies require identification ofthe products of drug candidate metabolism,...
Read More

BioLine

Holographic Analyses Devices The objective of the BioLine project is to further validate and optimize Ovizio’s technology for cell culture monitoring allowing it to analyze in a non invasive and reliable way, key cell culture parameters like cell numbers, cell morphology, viability, distribution of cell sizes and the presence of...
Read More

DNAVAC

Development and production of DNA vaccines without antibiotic resistance gene DNA vaccination seems to be a promising method of fighting diseases. For this application, plasmid DNA is injected into the subject (man or animal). This plasmid DNA encodes for an antigen that will be produced by the subject’s cells. In...
Read More

BIOCLOUD 4.0

The health sector sees the emergence of new generations of innovative therapies, among which promising approaches are related to gene and cell therapies. This evolution often leads to the deployment of patient-centric processes, implying not only dramatic changes in the bio-production processes but also significant increases of the treatment costs....
Read More

IT-Targets

Identification of drug candidates and biomarkers for immunotherapy (cancer and autoimmune diseases) IT-Targets project aims to identify innovative drugs candidates and biomarkers for cancer immunotherapy and auto-immune diseases in order to improve the response of patients to immunotherapy. The strategy is based on sampling human clinical samples, purify the different...
Read More

Improve

Optimization of the treatment with HepaMune in fibro-inflammatory chronic liver diseases The aim of the IMPROVE project is to develop a new cell therapy product that will be used for the treatment of fibro-inflammatory chronic liver diseases. The objective is to develop a product exhibiting increased immuno-modulatory and anti-inflammatory potential,...
Read More